ARTICLE SUMMARY:
Translating cancer genomic research tools into tools that are useful for patients is a passion of this start-up, founded by oncology genetics thought-leaders from Johns Hopkins University.
Over the p ast 25 years, pioneering researchers at The Johns Hopkins University (JHU) have been at the forefront of scientific advances that have led scientists to re-consider many types of cancers as diseases of genes, as opposed to tissues.
